JOHN CRADDOCK to Transplantation, Homologous
This is a "connection" page, showing publications JOHN CRADDOCK has written about Transplantation, Homologous.
Connection Strength
0.136
-
Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab. Pediatr Hematol Oncol. 2024 May; 41(4):260-272.
Score: 0.044
-
Cytomegalovirus Retinitis in Pediatric Stem Cell Transplants: Report of a Recent Cluster and the Development of a Screening Protocol. Am J Ophthalmol. 2017 Mar; 175:8-15.
Score: 0.027
-
In Vivo T Cell Depletion with Myeloablative Regimens on Outcomes after Cord Blood Transplantation for Acute Lymphoblastic Leukemia in Children. Biol Blood Marrow Transplant. 2015 Dec; 21(12):2173-2179.
Score: 0.025
-
Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant. Mol Ther. 2013 Nov; 21(11):2113-21.
Score: 0.021
-
Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia. Blood. 2012 Jun 21; 119(25):6155-61.
Score: 0.020